This site is intended for US animal healthcare professionals
Click here for Pet Owner Site
CYTOPOINT™ is an excellent choice for owners who are looking for a long-lasting solution1
HARLEY, male, age 14, Yorkshire Terrier mix
Veterinarian: Dr Liz Hardesty, Murray Hill Veterinary Hospital, Beaverton, OR
Harley’s temperament and his owner’s schedule made daily pilling challenging
Presentation and history
Harley had received regular grooming at Dr Hardesty’s clinic for a number of years. The groomer began consistently noticing skin infections, ear infections and hot spots. Dr Hardesty treated Harley with antibiotics and prescribed daily oral tablets for the underlying itch. Harley’s condition improved and he had fewer secondary infections; however, due to Harley’s feisty temperament and the schedule issues resulting from having young children, his owner was having difficulty with daily pilling.
With two small children, Harley’s owner has a hectic schedule, and Harley is not an easy dog to pill. The daily oral dosing was adding to the stress of both owner and dog.
“Our experience with the daily pill was that it made it a little tough on our daily life. We had to remember to give it to him daily at the same time roughly, but he just has become sort of less of a priority now that kids are around, and it's been pretty difficult to give him the pill every day.”
— Meaghan Reiser, 6/22/16
Harley’s itch is controlled, and his owner loves the convenience of CYTOPOINT
When CYTOPOINT became available, Harley’s owner was very enthusiastic about trying it, so Dr Hardesty gave Harley the injection to control his chronic itch.
At the 30-day recheck, both Dr Hardesty and Harley’s owner were very pleased with Harley’s progress. Harley’s itching was controlled and his constant paw biting had stopped. His owner reported that he was more able to “be himself.” Dr Hardesty noted that, despite his age, Harley seemed to be more lively and energetic than he had been before, now that his chronic itch was no longer bothering him. — 6/22/16
“Harley's owner seemed very happy at the one-month recheck. It seemed like we had taken a weight off of her shoulders in terms of having to administer medication at home. I think it did improve their human-animal bond. I'm sure at home, she is able to spend some quality time with him…in ways other than struggling with medication.”
— Dr Liz Hardesty, 6/17/16
Indication: CYTOPOINT aids in the reduction of clinical signs associated with atopic dermatitis in dogs.
Reference: 1. Data on file, CYTOPOINT Case Studies, Zoetis LLC.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
© 2016 Zoetis Services LLC. All rights reserved. CYT-00090
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States